CN1314906A - 帕罗西汀的盐 - Google Patents

帕罗西汀的盐 Download PDF

Info

Publication number
CN1314906A
CN1314906A CN99810197A CN99810197A CN1314906A CN 1314906 A CN1314906 A CN 1314906A CN 99810197 A CN99810197 A CN 99810197A CN 99810197 A CN99810197 A CN 99810197A CN 1314906 A CN1314906 A CN 1314906A
Authority
CN
China
Prior art keywords
acid
methyl
phenyl
benzoic
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99810197A
Other languages
English (en)
Chinese (zh)
Inventor
V·W·雅赛维茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1314906A publication Critical patent/CN1314906A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
CN99810197A 1998-07-02 1999-06-30 帕罗西汀的盐 Pending CN1314906A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
GB9814316.7 1998-07-02

Publications (1)

Publication Number Publication Date
CN1314906A true CN1314906A (zh) 2001-09-26

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99810197A Pending CN1314906A (zh) 1998-07-02 1999-06-30 帕罗西汀的盐

Country Status (21)

Country Link
EP (1) EP1091958A1 (cs)
JP (1) JP2002519421A (cs)
KR (1) KR20010053337A (cs)
CN (1) CN1314906A (cs)
AP (1) AP2000002017A0 (cs)
AU (2) AU4903999A (cs)
BG (1) BG105204A (cs)
BR (1) BR9911679A (cs)
CA (1) CA2336470A1 (cs)
CZ (1) CZ20004923A3 (cs)
EA (1) EA200100098A1 (cs)
GB (1) GB9814316D0 (cs)
HU (1) HUP0103712A3 (cs)
ID (1) ID27766A (cs)
IL (1) IL140385A0 (cs)
NO (1) NO20006547L (cs)
PL (1) PL345365A1 (cs)
SK (1) SK20242000A3 (cs)
TR (1) TR200100055T2 (cs)
WO (1) WO2000001692A1 (cs)
ZA (2) ZA992899B (cs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109212055A (zh) * 2018-08-19 2019-01-15 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633A (zh) * 2018-11-27 2019-02-15 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN116283778A (zh) * 2023-02-23 2023-06-23 江苏理工学院 一种吡唑羧酸类化合物及其制备方法和应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622630B1 (en) 2003-05-07 2012-08-29 Osteologix A/S Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
US20080167513A1 (en) 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
KR100672184B1 (ko) * 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
ES2745411T3 (es) 2006-07-27 2020-03-02 Wang Nai Fang Compuestos y composiciones de arilsulfanilo para administración de agentes activos
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
SK11812000A3 (sk) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Soli paroxetínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109212055A (zh) * 2018-08-19 2019-01-15 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633A (zh) * 2018-11-27 2019-02-15 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN116283778A (zh) * 2023-02-23 2023-06-23 江苏理工学院 一种吡唑羧酸类化合物及其制备方法和应用

Also Published As

Publication number Publication date
ZA200100020B (en) 2002-03-25
BG105204A (en) 2001-11-30
NO20006547D0 (no) 2000-12-21
KR20010053337A (ko) 2001-06-25
ZA992899B (en) 2000-03-29
TR200100055T2 (tr) 2001-07-23
BR9911679A (pt) 2002-01-29
HUP0103712A2 (hu) 2002-05-29
HUP0103712A3 (en) 2002-09-30
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (cs) 2001-08-15
AU4903999A (en) 2000-01-24
GB9814316D0 (en) 1998-09-02
IL140385A0 (en) 2002-02-10
NO20006547L (no) 2001-02-12
EA200100098A1 (ru) 2001-08-27
PL345365A1 (en) 2001-12-17
JP2002519421A (ja) 2002-07-02
AU2002100370A4 (en) 2002-06-06
SK20242000A3 (sk) 2001-07-10
ID27766A (id) 2001-04-26
WO2000001692A1 (en) 2000-01-13
EP1091958A1 (en) 2001-04-18
CA2336470A1 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
CN1314906A (zh) 帕罗西汀的盐
DE69527798T2 (de) Substituierte 4-biarylbutyr-oder 5-biarylpentasäuren und derivate als matrix metalloprotease inhibitoren
Cabré et al. Analgesic, antiinflammatory, and antipyretic effects of S (+)‐ketoprofen in vivo
TWI445529B (zh) 經醯基胺基取代之稠合環戊烷羧酸衍生物及其作為醫藥品之用途
AU637756B2 (en) Isoprenoid phospholipase a2 inhibitors and preparations comprising same
CA2131802A1 (en) Antipyretic and analgesic methods and compositions containing optically pure r(-)ketoprofen
FR2685916A1 (fr) Inhibiteurs mixtes de la no synthase et de la cyclooxygenase, ainsi qu'un procede pour leur preparation.
KR950005821A (ko) 융합된 페놀 유도체
Lee et al. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors
KR101194968B1 (ko) Ｐｔｐ 1-ｂ 저해제로서의 1,1’-(1,2-에틴디일)비스-벤젠유도체
RU96103662A (ru) Новые ретиноиды
JP7429998B2 (ja) ３―アリールオキシル―３―５員ヘテロアリール―プロピルアミン化合物およびその結晶形態ならびに用途
EP2207541B1 (en) Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
JP2003535098A (ja) 網膜疾患および緑内障を治療するためのｎａａｌａｄアーゼ阻害剤
CA2512563C (en) Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
US20040186081A1 (en) Naaladase inhibitors for treating opioid tolerance
GR3023729T3 (en) (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them.
JP2008523052A (ja) 置換ピロール誘導体
JP2001513526A (ja) アントラニル酸類似体
US20030130343A1 (en) Fat accumulation-modulating compounds
MXPA01000133A (en) Salts of paroxetine
US4529737A (en) Analgesic and anti-inflammatory arylalkanoic acid phthalidyl esters and pharmaceutical compositions thereof
JPWO2005087713A1 (ja) アミド化合物、医薬組成物及びｒｘｒ機能調節剤
WO2012174926A1 (zh) N-取代异丙二甲薁磺酰胺类衍生物及其制备方法和用途
JPH02783A (ja) （＋）２―（４―フルオロフェニル）―α―メチル―５―ベンズオキサゾール酢酸の水溶性塩及びそれらの製造方法

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication